Voyageur Pharmaceuticals Ltd (VM.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
| 02-2023 | 11-2022 | 08-2022 | 05-2022 | 02-2022 | |
| Operating Expenses | 374 | 573 | 427 | 477 | 247 |
| Operating Income | -374 | -573 | -427 | -477 | -247 |
| Other Income | 0 | -2 | 0 | 0 | 0 |
| Pre-tax Income | -374 | -575 | -427 | -477 | -247 |
| Net Income Continuous | -374 | -575 | -427 | -477 | -247 |
| Net Income | $-374 | $-575 | $-427 | $-477 | $-247 |
| EPS Basic Total Ops | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| EPS Basic Continuous Ops | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| EPS Diluted Total Ops | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| EPS Diluted Continuous Ops | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| EBITDA(a) | $-373 | $-568 | $-426 | $-476 | $-247 |